Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer.

Abstract:

BACKGROUND:The aim of this study was to evaluate the concentrations of IgG antibodies against Hsp60 and Hsp65 in sera of patients with ovarian cancer at various stages of clinical progress and for different histopathological types of disease. METHODS:Serum samples from 149 patients with ovarian carcinoma and 80 healthy women were investigated. The concentrations of anti-Hsp60 and anti-Hsp65 antibodies were determined using the enzyme-linked immunosorbent assay technique. RESULTS:The mean concentrations of anti-Hsp60 and anti-Hsp65 antibodies in the patients with ovarian cancer did not differ significantly from the mean levels in healthy women. Analysis in relation to the clinical progression stage showed that the concentrations of these antibodies were higher when the neoplastic process was less advanced and at early stages significantly higher than in control group. Mean concentrations of both antibodies were not significantly different in relation to the histological type of the ovarian cancer. The use of chemotherapy as a primary anticancer treatment did not cause a significant change in the concentration of anti-Hsp60 antibodies, but the mean level of anti-Hsp65 after this treatment was significantly higher than in control group. CONCLUSIONS:The immunological response to Hsp60/65 is increased in early clinical stages of ovarian cancer and the level of anti-hsp60/65 antibodies may be then a helpful diagnostic marker. Even antibodies against highly homologous Hsps may be cross-reactive only partially and differ by some functional properties.

journal_name

J Ovarian Res

authors

Bodzek P,Partyka R,Damasiewicz-Bodzek A

doi

10.1186/1757-2215-7-30

subject

Has Abstract

pub_date

2014-03-11 00:00:00

pages

30

issn

1757-2215

pii

1757-2215-7-30

journal_volume

7

pub_type

杂志文章
  • Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.

    abstract:BACKGROUND:Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53 status. METHODS:Sur...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-4-20

    authors: Felisiak-Golabek A,Rembiszewska A,Rzepecka IK,Szafron L,Madry R,Murawska M,Napiorkowski T,Sobiczewski P,Osuch B,Kupryjanczyk J,Polish Ovarian Cancer Study Group (POCSG).

    更新日期:2011-11-10 00:00:00

  • Changes in granulosa cells gene expression associated with growth, plateau and atretic phases in medium bovine follicles.

    abstract:BACKGROUND:The objective of this study was to build the transcriptomic profile of granulosa cells originating from follicles 6 to 9 mm in diameter in dairy cattle using microarrays. METHODS:Granulosa cells originating from three different phases of antral follicle growth were compared: growing (G), plateau (P) and atr...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-7-50

    authors: Douville G,Sirard MA

    更新日期:2014-05-07 00:00:00

  • Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women.

    abstract:BACKGROUND:Myo-inositol (MI), successfully used in polycystic ovary syndrome (PCOS), was administered with α-LA to exploit its action of favouring the passage of other molecules through biological barriers, and also considering its anti-inflammatory effect. METHODS:PCOS patients, according to the Rotterdam ESHRE-ASRM ...

    journal_title:Journal of ovarian research

    pub_type: 临床试验,杂志文章

    doi:10.1186/s13048-018-0411-2

    authors: Montanino Oliva M,Buonomo G,Calcagno M,Unfer V

    更新日期:2018-05-10 00:00:00

  • A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy.

    abstract:BACKGROUND:In this study we aimed to identify a prognostic signature in BRCA1/2 mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from gynecologic cancer in women worldwide. METHODS:Univariate Cox proportional-hazards and multivariate...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00712-w

    authors: Pan Y,Jia LP,Liu Y,Han Y,Li Q,Zou Q,Zhang Z,Huang J,Deng Q

    更新日期:2020-09-19 00:00:00

  • WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells.

    abstract:BACKGROUND:Wnt-inducible signaling pathway protein 2 (WISP2) is a wnt1-induced signaling pathway protein 2. Although studies indicate that WISP2 may promote the development of various tumors, its role in ovarian cancer remains unclear. The objective of the current study was to analyze the effects of WISP2 on the prolif...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00687-8

    authors: Shi ZQ,Chen ZY,Han Y,Zhu HY,Lyu MD,Zhang H,Zhang Y,Yang LQ,Pan WW

    更新日期:2020-07-25 00:00:00

  • Rate of rebound in follicle growth after cessation of ovarian stimulation in initial non-responders: a prospective cohort study.

    abstract::Previously anecdotally observed rebounds in follicle growth after interruption of exogenous gonadotropins in absolute non-responders were the impetus for here reported study. In a prospective cohort study, we investigated 49 consecutive patients, absolutely unresponsive to maximal exogenous gonadotropin stimulation, f...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00765-5

    authors: Gleicher N,Weghofer A,Darmon SK,Barad DH

    更新日期:2021-01-09 00:00:00

  • Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison.

    abstract:BACKGROUND:Ovarian thecoma-fibroma groups (OTFG) are uncommon sex cord-stromal neoplasms. The objective of the study was to demonstrate clinical and sonographic features of OTFG and compare with surgical histopathology. METHODS:A total of 61 patients with surgically proven OTFG were enrolled in this retrospective stud...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0291-2

    authors: Chen H,Liu Y,Shen LF,Jiang MJ,Yang ZF,Fang GP

    更新日期:2016-11-22 00:00:00

  • Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue.

    abstract:BACKGROUND:Because higher survival of follicles during the freezing/thawing procedure improves the quality of cryopreserved tissue reimplanted after oncological therapies, defining an optimal method for human ovarian tissue cryopreservation remains a major issue in this field. One option to improve the cryopreservation...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0268-1

    authors: Scheiner D,Bracone G,Imesch P,Fink D,Hehl J,Imthurn B

    更新日期:2016-09-26 00:00:00

  • Biological effects of combined resveratrol and vitamin D3 on ovarian tissue.

    abstract:BACKGROUND:Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural antioxidant polyphenol able to exert a wide range of biological effect on several tissues. Despite its important beneficial properties, it has a low water solubility, which limits its therapeutic applications in humans. Resveratrol also acts as a ph...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-017-0357-9

    authors: Uberti F,Morsanuto V,Aprile S,Ghirlanda S,Stoppa I,Cochis A,Grosa G,Rimondini L,Molinari C

    更新日期:2017-09-15 00:00:00

  • Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model.

    abstract:BACKGROUND:The polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine condition characterized by hyperandrogenism, hyperinsulinemia, insulin resistance and chronic anovulation. Regulation and interaction of a multitude of genes required for follicular development are found to be altered in PCOS. Micr...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-6-36

    authors: Hossain MM,Cao M,Wang Q,Kim JY,Schellander K,Tesfaye D,Tsang BK

    更新日期:2013-05-15 00:00:00

  • Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).

    abstract:BACKGROUND:Ovarian hyperstimulation syndrome (OHSS) is a rare, yet severe, iatrogenic complication of ovulation induction therapy during assisted reproductive procedures. Our group previously detected atypical cells in the ascitic fluid of OHSS patients, although no malignancy developed during follow up. Here, the aim ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00624-9

    authors: Farkas B,Boldizsar F,Bohonyi N,Farkas N,Marczi S,Kovacs GL,Bodis J,Koppan M

    更新日期:2020-03-05 00:00:00

  • SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling.

    abstract:BACKGROUND:The prevalence of obesity is increasing worldwide and significantly affects fertility and reproduction in both men and women. Our recent study has shown that excess body fat accelerates ovarian follicle development and follicle loss in rats. The aim of the present study is to explore the effect of SIRT1 acti...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-014-0097-z

    authors: Zhou XL,Xu JJ,Ni YH,Chen XC,Zhang HX,Zhang XM,Liu WJ,Luo LL,Fu YC

    更新日期:2014-10-21 00:00:00

  • With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization.

    abstract:BACKGROUND:Highly Individualized Egg Retrieval (HIER), defined as age-specific early oocyte retrieval (ER), has been demonstrated to avoid premature luteinization in women ≥43. We here investigated whether HIER also applies to younger women with premature ovarian aging (POA), and what best lead follicle size should be ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-018-0398-8

    authors: Wu YG,Barad DH,Kushnir VA,Wang Q,Zhang L,Darmon SK,Albertini DF,Gleicher N

    更新日期:2018-03-16 00:00:00

  • MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.

    abstract:BACKGROUND:Recent studies have shown that microRNAs may regulate the ABCB1 gene (ATP-binding cassette, sub-family B [MDR/TAP], member 1). Computational programs have predicted that the 3'-untranslated region (3'-UTR) of ABCB1 contains a potential miRNA-binding site for miR-186. Here, we investigated the role of miR-186...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-015-0207-6

    authors: Sun KX,Jiao JW,Chen S,Liu BL,Zhao Y

    更新日期:2015-12-02 00:00:00

  • Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression.

    abstract:BACKGROUND:Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme that reacts with hydrogen peroxide and soluble fatty acid hydroperoxides, thereby helping to maintain redox balance within cells. Serum levels of GPX3 have been found to be reduced in various cancers including prostrate, thyroi...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-4-18

    authors: Agnani D,Camacho-Vanegas O,Camacho C,Lele S,Odunsi K,Cohen S,Dottino P,Martignetti JA

    更新日期:2011-10-22 00:00:00

  • Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report.

    abstract:BACKGROUND:The value of this report is the identification of late recurrence with an extremely unusual combination of malignant transformation. In particular, the retroconversion of immature to mature teratoma as well as a somatic-type malignant transformation were both observed postchemotherapeutically in our case. C...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-018-0476-y

    authors: Lee YL,Lai CR,Yen MS

    更新日期:2019-01-10 00:00:00

  • Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.

    abstract::Following publication of the original article [1], the authors opted to correct the incorrect e-mail address of the corresponding author from 82-55-360-1850chungsu1982@gmail.com to chungsu1982@gmail.com , grant in the Acknowledgements section and Author details. Below are the updated version of the Acknowledgements an...

    journal_title:Journal of ovarian research

    pub_type: 已发布勘误

    doi:10.1186/s13048-019-0540-2

    authors: Kim KH,Choi KU,Kim A,Lee SJ,Lee JH,Suh DS,Kwon BS,Hwang C

    更新日期:2019-07-23 00:00:00

  • Proactive use of PROMs in ovarian cancer survivors: a systematic review.

    abstract:INTRODUCTION:The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of PROMs during treatment improves patient-clinician communication, leads to better symptom managem...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-019-0538-9

    authors: Kargo AS,Coulter A,Jensen PT,Steffensen KD

    更新日期:2019-07-15 00:00:00

  • Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.

    abstract:BACKGROUND:The mechanism of aggressive character of ovarian cancer and unsuccessful treatment of women with this deadly disease has been recently explained by the theory of cancer stem cells (CSCs). It has been reported that ovarian carcinogenesis and progression of disease is associated with epithelial-mesenchymal tra...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-017-0306-7

    authors: Kenda Suster N,Smrkolj S,Virant-Klun I

    更新日期:2017-02-23 00:00:00

  • Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers.

    abstract:RATIONALE AND OBJECTIVES:To evaluate the impact of metabolic parameters in the peritoneal cavity on the likelihood of achieving complete tumor debulking in patients with ovarian and peritoneal cancers. MATERIALS AND METHODS:Forty-nine patients with ovarian and peritoneal cancers were included, who underwent pre-operat...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00662-3

    authors: Tsoi TT,Chiu KWH,Chu MY,Ngan HYS,Lee EYP

    更新日期:2020-05-20 00:00:00

  • Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer.

    abstract:BACKGROUND:Epithelial ovarian cancer has the highest fatality rate of all gynecologic malignancies. Although the majority of patients achieve complete clinical response after initial cytoreductive surgery and platinum-based chemotherapy, most recur and almost all will eventually acquire platinum-resistance for which tr...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0506-4

    authors: Cohen S,Schwartz M,Dottino P,Beddoe AM

    更新日期:2019-04-25 00:00:00

  • Determination of sialic acid in saliva by means of surface-enhanced Raman spectroscopy as a marker in adnexal mass patients: ovarian cancer vs benign cases.

    abstract:BACKGROUND:To demonstrate the use of surface-enhanced Raman spectroscopy (SERS) to determine sialic acid (SA) levels in saliva using silver nanoparticles as substrates, in adnexal mass patients scheduled for surgical intervention to remove invasive masses, with the aim to compare SA levels in benign tumor vs ovarian ca...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-018-0433-9

    authors: Zermeño-Nava JJ,Martínez-Martínez MU,Rámirez-de-Ávila AL,Hernández-Arteaga AC,García-Valdivieso MG,Hernández-Cedillo A,José-Yacamán M,Navarro-Contreras HR

    更新日期:2018-07-24 00:00:00

  • Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.

    abstract:BACKGROUND:The majority of death-related ovarian cancer is epithelial ovarian cancer (EOC). Regarding the Federation of Gynecology and Obstetrics (FIGO) stage IV EOC, the 5-year overall survival (OS) has not changed in last decades. Platelet (PLT) count and CA125 level are both prognostic markers that related to inflam...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0544-y

    authors: Chen JP,Huang QD,Wan T,Tu H,Gu HF,Cao JY,Liu JH

    更新日期:2019-07-31 00:00:00

  • SNAP23 promotes the malignant process of ovarian cancer.

    abstract:BACKGROUND:Ovarian cancer (OC) was the primary malignant gynecological cancer and SNARE protein is closely related with tumor progression. Here, we identified SNAP23, a member of SNARE complex, as a potential oncogene in OC. METHODS:We determined the expression of SNAP23 in OC tissues and explored the clinical signifi...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0289-9

    authors: Sun Q,Huang X,Zhang Q,Qu J,Shen Y,Wang X,Sun H,Wang J,Xu L,Chen X,Ren B

    更新日期:2016-11-17 00:00:00

  • Correction to: Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.

    abstract::AbstractThe original article [1] contains errors in Figs. 6 and 8. The corrected figures can be shown ahead. ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s13048-019-0487-3

    authors: Ling K,Jiang L,Liang S,Kwong J,Yang L,Li Y,PingYin,Deng Q,Liang Z

    更新日期:2019-01-30 00:00:00

  • Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer.

    abstract:OBJECTIVE:Recently, 14-3-3 zeta protein was identified as a potential serum biomarker of epithelial ovarian cancer (EOC). The goal of this study was to investigate the clinical potential of 14-3-3 zeta protein for monitoring EOC progression compared with CA-125 and HE4. DESIGN:Prospective follow-up study. SETTING:Uni...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-6-79

    authors: Hatzipetros I,Gocze P,Koszegi T,Jaray A,Szereday L,Polgar B,Farkas N,Farkas B

    更新日期:2013-11-15 00:00:00

  • The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.

    abstract:BACKGROUND:The down-regulation of E-cadherin gene (CDH1) expression has been regarded as an important event in cancer invasion and metastasis. However, the association between CDH1 promoter methylation and ovarian cancer remains unclear. A meta-analysis was conducted to evaluate the potential role of CDH1 promoter meth...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13048-016-0231-1

    authors: Wang Q,Wang B,Zhang YM,Wang W

    更新日期:2016-04-11 00:00:00

  • FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.

    abstract:BACKGROUND:Whether there is a mechanistic link between FOLR1 and response to cisplatin has not been extensively examined. In this study, we determine the expression of FOLR1 in ovarian cancer and examine if FOLR1 levels influence response to cisplatin. RESULTS:(1) FOLR1 protein expression was lowest in normal ovarian ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-018-0387-y

    authors: Huang MJ,Zhang W,Wang Q,Yang ZJ,Liao SB,Li L

    更新日期:2018-02-13 00:00:00

  • Use of aromatase inhibitors in practice of gynecology.

    abstract:PURPOSE:The conversion of androgens into estrogens by aromatase is called aromatization and is inhibited by aromatase inhibitors (AIs). The aim of this article is to evaluate the use of aromatase inhibitors in gynecological diseases such as endometriosis, leiomyoma, estrogen- dependent gynecologic neoplasia and inferti...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-015-0131-9

    authors: Usluogullari B,Duvan C,Usluogullari C

    更新日期:2015-02-25 00:00:00

  • Retraction note: The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel.

    abstract::The Publisher and Editor regretfully retract this article ( Hou W, Guan J, Lu H, Dong Q, Han Y, Zhang R. The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel. J Ovarian Res. 2014;7:89) because the peer-review process was inappropriately influenced and comp...

    journal_title:Journal of ovarian research

    pub_type: 撤回出版物

    doi:10.1186/s13048-015-0144-4

    authors:

    更新日期:2015-03-26 00:00:00